Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 17-May-22 5:12 PM View:  | Venbio Global Strategic Fun... 10% Owner | Checkmate Pharmaceuticals, ... (CMPI) | 16-May-22 | Sale | 95,800 | $10.45 | $1,001,100.00 | (4%) 2.25M to 2.16M | |
| 17-May-22 5:12 PM View: | Venbio Global Strategic Fun... 10% Owner | Checkmate Pharmaceuticals, ... (CMPI) | 13-May-22 | Private Sale | 35,850 | $10.45 | $374,464.00 | (2%) 2.29M to 2.25M | |
| 12-May-22 8:47 PM View: | Venbio Global Strategic Fun... 10% Owner | Checkmate Pharmaceuticals, ... (CMPI) | 12-May-22 | Sale | 124,525 | $10.39 | $1,294,310.00 | (5%) 2.41M to 2.29M | |
| 12-May-22 8:47 PM View: | Venbio Global Strategic Fun... 10% Owner | Checkmate Pharmaceuticals, ... (CMPI) | 11-May-22 | Sale | 17,700 | $10.38 | $183,641.00 | (< 1%) 2.43M to 2.41M | |
| 12-May-22 8:47 PM View: | Venbio Global Strategic Fun... 10% Owner | Checkmate Pharmaceuticals, ... (CMPI) | 10-May-22 | Private Sale | 18,676 | $10.38 | $193,870.00 | (< 1%) 2.45M to 2.43M | |
| 09-May-22 6:58 PM View: | Venbio Global Strategic Fun... 10% Owner | Checkmate Pharmaceuticals, ... (CMPI) | 09-May-22 | Sale | 17,600 | $10.37 | $182,582.00 | (< 1%) 2.47M to 2.45M | |
| 09-May-22 6:58 PM View: | Venbio Global Strategic Fun... 10% Owner | Checkmate Pharmaceuticals, ... (CMPI) | 06-May-22 | Sale | 48,334 | $10.37 | $501,233.00 | (2%) 2.51M to 2.47M | |
| 09-May-22 6:58 PM View: | Venbio Global Strategic Fun... 10% Owner | Checkmate Pharmaceuticals, ... (CMPI) | 05-May-22 | Private Sale | 20,743 | $10.37 | $215,105.00 | (< 1%) 2.54M to 2.51M | |
| 04-May-22 7:30 PM View: | Venbio Global Strategic Fun... 10% Owner | Checkmate Pharmaceuticals, ... (CMPI) | 04-May-22 | Sale | 37,500 | $10.37 | $388,924.00 | (1%) 2.57M to 2.54M | |
| 04-May-22 7:30 PM View: | Venbio Global Strategic Fun... 10% Owner | Checkmate Pharmaceuticals, ... (CMPI) | 03-May-22 | Sale | 79,475 | $10.37 | $824,434.00 | (3%) 2.65M to 2.57M | |
| 04-May-22 7:30 PM View: | Venbio Global Strategic Fun... 10% Owner | Checkmate Pharmaceuticals, ... (CMPI) | 02-May-22 | Private Sale | 153,700 | $10.38 | $1,595,970.00 | (5%) 2.81M to 2.65M | |
| 29-Apr-22 5:50 PM View: | Venbio Global Strategic Fun... 10% Owner | Checkmate Pharmaceuticals, ... (CMPI) | 29-Apr-22 | Sale | 69,230 | $10.38 | $718,663.00 | (2%) 2.88M to 2.81M | |
| 29-Apr-22 5:50 PM View: | Venbio Global Strategic Fun... 10% Owner | Checkmate Pharmaceuticals, ... (CMPI) | 28-Apr-22 | Sale | 73,400 | $10.38 | $761,936.00 | (2%) 2.95M to 2.88M | |
| 29-Apr-22 5:50 PM View: | Venbio Global Strategic Fun... 10% Owner | Checkmate Pharmaceuticals, ... (CMPI) | 27-Apr-22 | Private Sale | 47,396 | $10.38 | $491,980.00 | (2%) 3.0M to 2.95M | |
| 26-Apr-22 6:40 PM View: | Venbio Global Strategic Fun... 10% Owner | Checkmate Pharmaceuticals, ... (CMPI) | 26-Apr-22 | Sale | 64,683 | $10.38 | $671,558.00 | (2%) 3.06M to 3.0M | |
| 26-Apr-22 6:40 PM View: | Venbio Global Strategic Fun... 10% Owner | Checkmate Pharmaceuticals, ... (CMPI) | 25-Apr-22 | Sale | 27,668 | $10.39 | $287,404.00 | (< 1%) 3.09M to 3.06M | |
| 26-Apr-22 6:40 PM View: | Venbio Global Strategic Fun... 10% Owner | Checkmate Pharmaceuticals, ... (CMPI) | 22-Apr-22 | Private Sale | 37,430 | $10.39 | $388,834.00 | (1%) 3.13M to 3.09M | |
| 21-Apr-22 8:54 PM View: | Venbio Global Strategic Fun... 10% Owner | Checkmate Pharmaceuticals, ... (CMPI) | 21-Apr-22 | Sale | 62,200 | $10.38 | $645,866.00 | (2%) 3.19M to 3.13M | |
| 21-Apr-22 8:54 PM View: | Venbio Global Strategic Fun... 10% Owner | Checkmate Pharmaceuticals, ... (CMPI) | 20-Apr-22 | Sale | 85,611 | $10.39 | $889,387.00 | (3%) 3.27M to 3.19M | |
| 21-Apr-22 8:54 PM View: | Venbio Global Strategic Fun... 10% Owner | Checkmate Pharmaceuticals, ... (CMPI) | 19-Apr-22 | Private Sale | 399,923 | $10.42 | $4,165,240.00 | (11%) 3.67M to 3.27M | |
| 25-Feb-22 6:21 PM View: | Novo A/s 10% Owner | Checkmate Pharmaceuticals, ... (CMPI) | 25-Feb-22 | Sale | 300 | $2.70 | $810.96 | (< 1%) 2.16M to 2.16M | |
| 25-Feb-22 6:21 PM View: | Novo A/s 10% Owner | Checkmate Pharmaceuticals, ... (CMPI) | 24-Feb-22 | Sale | 5,990 | $2.83 | $16,978.70 | (< 1%) 2.17M to 2.16M | |
| 25-Feb-22 6:21 PM View: | Novo A/s 10% Owner | Checkmate Pharmaceuticals, ... (CMPI) | 23-Feb-22 | Sale | 1,820 | $2.90 | $5,277.45 | (< 1%) 2.17M to 2.17M | |
| 21-Jun-21 4:26 PM View: | Krieg Arthur M Chief Scientific Officer | Checkmate Pharmaceuticals, ... (CMPI) | 18-Jun-21 | Market Purchase | 7,224 | $6.04 | $43,633.00 | < 1% 808.51K to 815.73K | < 1% |
| 17-Jun-21 4:33 PM View: | Krieg Arthur M Chief Scientific Officer | Checkmate Pharmaceuticals, ... (CMPI) | 16-Jun-21 | Market Purchase | 3,578 | $6.18 | $22,112.00 | < 1% 804.93K to 808.51K | 1% |
| 01-Jun-21 6:44 PM View: | Krieg Arthur M Chief Scientific Officer | Checkmate Pharmaceuticals, ... (CMPI) | 28-May-21 | Disposition (other) | 205,371 | -- | -- | (20%) 1.01M to 804.93K | |
| 19-May-21 4:15 PM View: | Krieg Arthur M Chief Scientific Officer | Checkmate Pharmaceuticals, ... (CMPI) | 18-May-21 | Market Purchase | 25,001 | $6.97 | $174,257.00 | 3% 848.39K to 873.39K | (3%) |
| 31-Mar-21 8:12 PM View: | Krieg Arthur M Chief Scientific Officer | Checkmate Pharmaceuticals, ... (CMPI) | 29-Mar-21 | Market Purchase | 33,220 | $11.16 | $370,673.00 | 4% 815.17K to 848.39K | (7%) |
| 29-Mar-21 4:20 PM View: | Krieg Arthur M Chief Scientific Officer | Checkmate Pharmaceuticals, ... (CMPI) | 26-Mar-21 | Market Purchase | 3,484 | $12.15 | $42,330.60 | < 1% 811.68K to 815.17K | < 1% |
| 29-Mar-21 4:20 PM View: | Krieg Arthur M Chief Scientific Officer | Checkmate Pharmaceuticals, ... (CMPI) | 25-Mar-21 | Market Purchase | 10,036 | $12.35 | $123,945.00 | 1% 801.65K to 811.68K | (< 1%) |
| 01-Mar-21 4:15 PM View: | Chaudhary Kleem Chief Business Officer | Checkmate Pharmaceuticals, ... (CMPI) | 26-Feb-21 | Option Exercise | 2,000 | $2.62 | $5,240.00 | 33% 6.0K to 8.0K | |
| 28-Jan-21 4:05 PM View: | Krieg Arthur M Chief Scientific Officer | Checkmate Pharmaceuticals, ... (CMPI) | 27-Jan-21 | Market Purchase | 1,701 | $13.05 | $22,198.10 | < 1% 799.95K to 801.65K | 11% |
| 21-Jan-21 5:17 PM View: | Krieg Arthur M Chief Scientific Officer | Checkmate Pharmaceuticals, ... (CMPI) | 19-Jan-21 | Market Purchase | 500 | $13.09 | $6,545.00 | < 1% 799.45K to 799.95K | 9% |
| 15-Jan-21 4:30 PM View: | Chaudhary Kleem Chief Business Officer | Checkmate Pharmaceuticals, ... (CMPI) | 14-Jan-21 | Option Exercise | 2,000 | $2.62 | $5,240.00 | 50% 4.0K to 6.0K | |
| 31-Dec-20 4:20 PM View: | Krieg Arthur M Chief Scientific Officer | Checkmate Pharmaceuticals, ... (CMPI) | 29-Dec-20 | Market Purchase | 443 | $14.16 | $6,272.88 | < 1% 799.0K to 799.45K | 6% |
| 23-Dec-20 4:15 PM View: | Chaudhary Kleem Chief Business Officer | Checkmate Pharmaceuticals, ... (CMPI) | 22-Dec-20 | Option Exercise | 4,000 | $2.62 | $10,480.00 | 100% 0 to 4.0K | |
| 23-Dec-20 4:13 PM View: | Krieg Arthur M Chief Scientific Officer | Checkmate Pharmaceuticals, ... (CMPI) | 22-Dec-20 | Market Purchase | 5,103 | $14.64 | $74,707.90 | < 1% 793.9K to 799.0K | 2% |
| 17-Dec-20 5:21 PM View: | Krieg Arthur M Chief Scientific Officer | Checkmate Pharmaceuticals, ... (CMPI) | 16-Dec-20 | Purchase | 4,805 | $14.62 | $70,249.10 | < 1% 789.1K to 793.9K | |
| 17-Dec-20 5:21 PM View: | Krieg Arthur M Chief Scientific Officer | Checkmate Pharmaceuticals, ... (CMPI) | 15-Dec-20 | Purchase | 42 | $14.49 | $608.58 | < 1% 789.05K to 789.1K | |
| 12-Aug-20 9:04 PM View: | Powell Michael Director 10% Owner | Checkmate Pharmaceuticals, ... (CMPI) | 11-Aug-20 | Conversion Duplicate | 3,473,370 | -- | -- | 100% 0 to 3.47M | |
| 12-Aug-20 9:00 PM View: | Venbio Global Strategic Fun... 10% Owner | Checkmate Pharmaceuticals, ... (CMPI) | 11-Aug-20 | Purchase | 200,000 | $15.00 | $3,000,000.00 | 6% 3.47M to 3.67M | |
| 13-Aug-20 4:52 PM View: | Novo A/s 10% Owner | Checkmate Pharmaceuticals, ... (CMPI) | 11-Aug-20 | Conversion | 1,670,100 | -- | -- | 100% 0 to 1.67M | |
| 12-Aug-20 9:04 PM View: | Powell Michael Director 10% Owner | Checkmate Pharmaceuticals, ... (CMPI) | 11-Aug-20 | Purchase | 133,333 | $15.00 | $2,000,000.00 | 4% 3.47M to 3.61M | |
| 13-Aug-20 4:52 PM View: | Novo A/s 10% Owner | Checkmate Pharmaceuticals, ... (CMPI) | 11-Aug-20 | Purchase | 500,000 | $15.00 | $7,500,000.00 | 30% 1.67M to 2.17M | |
| 12-Aug-20 9:00 PM View: | Venbio Global Strategic Fun... 10% Owner | Checkmate Pharmaceuticals, ... (CMPI) | 11-Aug-20 | Conversion | 3,473,370 | -- | -- | 100% 0 to 3.47M |
